Evidence map›Paper›PMID 37452350›Full record

ArticleJournal of medical case reports2023

Benefits of combined use of

Iulia Peciu-Florianu, Alice Jaillard, Constantin Tuleasca, Nicolas Reyns

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Iulia Peciu-FlorianuNeurosurgery Service, CHU Lille, Roger Salengro Hospital, Lille, France.
Alice JaillardNuclear Medicine and Functional Imaging, CHU Lille, Roger Salengro Hospital, Lille, France.
Constantin Tuleasca *Neurosurgery Service, CHU Lille, Roger Salengro Hospital, Lille, France. constantin.tuleasca@gmail.com.ORCID http://orcid.org/0000-0001-6776-1486
Nicolas Reyns *Neurosurgery Service, CHU Lille, Roger Salengro Hospital, Lille, France.
Centre Hospitalier Universitaire de Lille · FRUniversity Hospital of Lausanne · CH

Funding

Université de Lausanne Jeune Chercheur en Recherche Clinique
6 · The paper itself

Abstract

backgroundStudies of novel microsurgical adjuncts, such as 5-aminolevulinic acid (5-ALA) fluorescence have shown various fluorescence patterns within meningiomas, opening new avenues for complete microsurgical resection. Here, we present a recurrent, radiation-induced meningioma, previously operated on two occasions (initial gross total resection and subtotal 12 years later) and also irradiated by Gamma Knife radiosurgery (GKR, 6 years after the first surgery). We thought to assess the usefulness of CASE REPORT: We report on a 43 years-old Caucasian male diagnosed with atypical, radiation induced WHO II meningioma, with left basal temporal bone implantation. Hodgkin lymphoma treated with cranial and mediastinal radiation during infancy marked his personal history. He underwent a first gross total microsurgical resection, followed 6 and 12 years later by Gamma Knife radiosurgery (GKR) and second subtotal microsurgical resection, respectively. Magnetic resonance imaging (MRI) displayed new recurrence 13 years after initial diagnosis. He was clinically asymptomatic but routine Magnetic resonance imaging showed constant progression. There was strong

conclusionThe authors conclude that fluorescence-guided resection using 5-ALA is useful for recurrent atypical, radiation-induced meningioma even despite previous irradiation and multiple recurrences.

Indexed as

Meningeal NeoplasmsMeningiomaRadiosurgeryAdultAminolevulinic AcidHumansMaleMicrosurgeryNeoplasms, Radiation-InducedRetrospective StudiesSkullAminolevulinic Acid5-ALAAtypicalFluorescenceGamma KnifeMeningiomaRecurrent

Identifiers

PMID37452350
PMCPMC10349456
OpenAlexW4384296274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.